Bicycle Therapeutics plc (BCYC)

NASDAQ: BCYC · Real-Time Price · USD

4.355

-0.035 (-0.80%)

At close: Aug 26, 2026, 4:00 PM EDT

4.355

0.00 (0.00%)

After-hours: Aug 26, 2026, 4:10 PM EDT

Bicycle Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	510.05	628.11	879.52	526.42	339.15	438.68
Cash & Short-Term Investments	510.05	628.11	879.52	526.42	339.15	438.68
Cash Growth	-29.30%	-28.59%	67.07%	55.22%	-22.69%	222.58%
Accounts Receivable	-	-	-	-	2.05	1
Other Receivables	47.42	35.59	35.65	24.04	19.16	10.91
Receivables	47.42	35.59	35.65	24.04	21.21	11.91
Prepaid Expenses	17.77	19.18	13.43	11.41	9.02	7.97
Total Current Assets	575.24	682.89	928.61	561.87	369.38	458.56
Property, Plant & Equipment	18.67	21.91	17.19	27.68	32.77	17.79
Other Long-Term Assets	12.67	12.81	11.07	5.79	8.46	3.45
Total Assets	606.58	717.6	956.87	595.34	410.61	479.79

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	5.66	9.67	15.79	13.05	6.47	2.72
Accrued Expenses	37.95	41.46	35.45	26.38	21.86	11.29
Current Portion of Leases	0.98	2.76	5.5	4.88	3.13	2.38
Current Unearned Revenue	2.88	2.96	10.19	24.98	20.42	19.27
Other Current Liabilities	0.16	0.14	0.3	0.26	1.47	0.57
Total Current Liabilities	47.64	56.98	67.23	69.54	53.34	36.24
Long-Term Debt	-	-	-	30.7	30.32	29.87
Long-Term Leases	13.68	14.1	3.99	9.38	10.89	12.08
Long-Term Unearned Revenue	34.08	35.51	91.47	110.22	41.46	52.07
Other Long-Term Liabilities	0.93	1.03	1.12	4.58	3.83	3.28
Total Liabilities	96.32	107.62	163.81	224.41	139.83	133.54

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.9	0.89	0.89	0.55	0.39	0.38
Additional Paid-In Capital	1,526	1,512	1,473	883.45	601.11	567.64
Retained Earnings	-1,011	-899.75	-680.79	-511.76	-331.1	-218.38
Comprehensive Income & Other	-5.42	-3.51	0.12	-1.3	0.39	-3.39
Total Common Equity	510.26	609.98	793.06	370.93	270.78	346.25
Shareholders' Equity	510.26	609.98	793.06	370.93	270.78	346.25
Total Liabilities & Equity	606.58	717.6	956.87	595.34	410.61	479.79

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	14.66	16.85	9.49	44.96	44.33	44.34
Net Cash (Debt)	495.39	611.26	870.03	481.47	294.83	394.34
Net Cash Growth	-30.64%	-29.74%	80.70%	63.30%	-25.24%	228.03%
Net Cash Per Share	7.12	8.82	14.95	13.53	9.94	15.73
Filing Date Shares Outstanding	69.99	69.71	69.2	42.59	30.02	29.6
Total Common Shares Outstanding	69.81	69.37	69.06	42.43	29.87	29.58
Working Capital	527.6	625.9	861.38	492.33	316.04	422.32
Book Value Per Share	7.31	8.79	11.48	8.74	9.06	11.71
Tangible Book Value	510.26	609.98	793.06	370.93	270.78	346.25
Tangible Book Value Per Share	7.31	8.79	11.48	8.74	9.06	11.71
Machinery	19.01	19.06	16.53	16.91	16.24	7.11
Leasehold Improvements	12.41	12.03	10.9	11	10.74	0.81

SEC Filings: 10-K · 10-Q